Skip to main content
. 2021 Sep 29;10(19):4512. doi: 10.3390/jcm10194512

Figure 2.

Figure 2

Kaplan–Meier analysis of 30-day all-cause mortality in cardiogenic shock patients with high bio-ADM value at inclusion (≥53.8 pg/mL) vs. low bio-ADM (<53.8 pg/mL). Dichotomization of patients was based on bio-ADM value 53.8 mg/mL, which was the median value of bio-ADM at inclusion (interquartile range 28.5–85.2 pg/mL). + indicates censoring. bio-ADM, bioactive adrenomedullin; HR, hazard ratio.